Screening for new agonists against Alzheimer's disease

被引:50
|
作者
Zheng, Huiqin
Wei, Dong-Qing
Zhang, Rui
Wang, Chunfang
Wei, Huachun
Chou, Kuo-Chen
机构
[1] Shanghai Jiao Tong Univ, Coll Life Sci & Technol, Shanghai 200240, Peoples R China
[2] Tianjin Normal Univ, Inst Bioinformat & Drug Discovery, Tianjin 300074, Peoples R China
[3] Gordon Life Sci Inst, San Diego, CA 92130 USA
关键词
Alzheimer's disease; alpha; 7; receptor; GTS-21; pharmacophore alignment; docking; traditional chinese medicines database;
D O I
10.2174/157340607781745492
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
To find new drug candidates for treating Alzheimer's disease, we used the similarity search technique and GTS-21 as a template to search the Traditional Chinese Medicines Database. The high-score molecules thus obtained were compared with the template through the flexible alignment. Those molecules which had good alignment with GTS-21 were selected for conducting the docking studies aimed at the alpha 7 nicotinic acetylcholine receptor. The CHARMM22 force field was taken to compute the partial charge and the TABU search was adopted to operate the docking process. The docking results thus obtained were used to compare with that of GTS-21. Those molecules which had better docking results than that of GTS-21 were singled out for further consideration. Finally, it was found through an in-depth structural analysis that Mol 7235 might be a promising candidate for further modification by experiments to make it become an effective drug for treating Alzheimer's disease.
引用
收藏
页码:488 / 493
页数:6
相关论文
共 50 条
  • [21] Screening for New Biomarkers for Subcortical Vascular Dementia and Alzheimer's Disease
    Ohrfelt, Annika
    Andreasson, Ulf
    Simon, Adam
    Zetterberg, Henrik
    Edman, Ake
    Potter, William
    Holder, Daniel
    Devanarayan, Viswanath
    Seeburger, Jeffrey
    Smith, A. David
    Blennow, Kaj
    Wallin, Anders
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2011, 1 (01) : 31 - 42
  • [22] Genetic screening in Alzheimer's disease
    Tanzi, RE
    Blacker, D
    GENERATIONS-JOURNAL OF THE AMERICAN SOCIETY ON AGING, 2000, 24 (01): : 58 - 63
  • [23] M1 muscarinic agonists as a therapeutic strategy in Alzheimer's disease - M1 muscarinic agonists in Alzheimer's disease
    Fisher, A
    Pittel, Z
    Haring, R
    Brandeis, R
    Bar-Ner, N
    Sonego, H
    Marcovitch, I
    Natan, N
    Mestre-Frances, N
    Bons, N
    MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE, 2002, 51 : 205 - 210
  • [24] Cotinine: A Potential New Therapeutic Agent against Alzheimer's disease
    Echeverria, Valentina
    Zeitlin, Ross
    CNS NEUROSCIENCE & THERAPEUTICS, 2012, 18 (07) : 517 - 523
  • [25] Direct oral anticoagulants: a new therapy against Alzheimer's disease?
    Grossmann, Klaus
    NEURAL REGENERATION RESEARCH, 2021, 16 (08) : 1556 - 1557
  • [26] Microcurrent therapy as the nonpharmacological new protocol against Alzheimer's disease
    Kim, Eun Ho
    Lee, Won Seok
    Lee, Jae Hee
    Kwon, Dong Rak
    FRONTIERS IN AGING NEUROSCIENCE, 2024, 16
  • [28] From the ChiuZ - Storylab: New Approaches against Alzheimer's Disease
    John, Torsten
    CHEMIE IN UNSERER ZEIT, 2015, 49 (06) : 361 - 361
  • [29] A vaccine against Alzheimer's disease?
    Blasko, I
    Grubeck-Loebenstein, B
    WIENER KLINISCHE WOCHENSCHRIFT, 2003, 115 (09) : 279 - 280
  • [30] Protection against Alzheimer's disease?
    Burns, A
    Murphy, D
    LANCET, 1996, 348 (9025): : 420 - 421